Sergiy Klymenko

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Heinz Gisslinger, Christoph Klade, Pencho Georgiev et al. · The Lancet Haematology · 2020 · 327 citations

Polycythaemia Vera, Hematology, Clinical Trials +5

Expression of mi<scp>RNA</scp>‐26b‐5p and its target <scp>TRPS</scp>1 is associated with radiation exposure in post‐<scp>C</scp>hernobyl breast cancer

Christina Wilke, Sergiy Klymenko, V. Chumak et al. · International Journal of Cancer · 2017 · 39 citations · Full text

Overexpression of P-glycoprotein in L1210/VCR cells is associated with changes in several endoplasmic reticulum proteins that may be partially responsible for the lack of thapsigargin sensitivity.

Mário Šereš, Eva Polaková, Oľga Križanová et al. · PubMed · 2008 · 18 citations

Thapsigargin Sensitivity, Molecular Biology, Cellular Physiology +17

Hematopoietic cell infusion for the treatment of nuclear disaster victims: New data from the Chernobyl accident

Sergiy Klymenko, Joel Ross, Kouros Owzar et al. · International Journal of Radiation Biology · 2011 · 14 citations

A genomic copy number signature predicts radiation exposure in post‐<scp>C</scp>hernobyl breast cancer

Christina Wilke, Herbert Braselmann, Sergiy Klymenko et al. · International Journal of Cancer · 2018 · 13 citations · Full text